Welcome to the Disproportionality Analysis Tool
This interactive assistant will guide you through performing a disproportionality analysis for pharmacovigilance signal detection.
Disproportionality analysis identifies potential safety signals by checking if a drug and adverse event are reported together more often than expected by chance.
- Study Setup: Define your drug, adverse event, and analysis parameters
- Data Input: Enter contingency table data or individual reports
- Analysis: Calculate disproportionality measures (ROR, PRR, IC, etc.)
- Signal Assessment: Evaluate signal strength and significance
- Interpretation: Understand the clinical relevance of findings
- Export: Generate a report of your analysis
Reporting Odds Ratio (ROR): Measures how much more likely an adverse event is reported with a specific drug compared to all other drugs.
Proportional Reporting Ratio (PRR): Compares the proportion of a specific adverse event for one drug versus all other drugs.
Information Component (IC): A Bayesian measure that quantifies the strength of association between a drug and adverse event.
Contingency Table: A 2x2 table that organizes data for disproportionality analysis.
The Information Component (IC) is a Bayesian measure used in pharmacovigilance to detect drug-adverse event associations. It's part of the Bayesian Confidence Propagation Neural Network (BCPNN) method used by the WHO Uppsala Monitoring Centre.
Where: a = drug-event reports, b = drug reports without event, c = event reports without drug, N = total reports
How to Interpret IC Values
The IC value represents the strength of association between a drug and adverse event:
The event is not reported more frequently than expected
Minor association that may warrant monitoring
Noticeable association that requires investigation
Strong association that needs immediate attention
Advantages of IC
- Bayesian approach: Incorporates prior knowledge and handles uncertainty better
- Stable with sparse data: Performs better than frequentist methods with small numbers
- Provides probability estimates: Gives the probability of a true association
- Widely used: Employed by WHO's global pharmacovigilance database
Scenario: A new antidepressant and reports of serotonin syndrome
- Drug-event reports (a): 25
- Drug reports without event (b): 2,500
- Event reports without drug (c): 100
- Total reports in database (N): 1,000,000
Interpretation: Strong signal (IC > 2). Serotonin syndrome is reported much more frequently with this antidepressant than expected.
Scenario: A diabetes medication and reports of pancreatitis
- Drug-event reports (a): 45
- Drug reports without event (b): 14,955
- Event reports without drug (c): 370
- Total reports in database (N): 200,000
Interpretation: Moderate signal (1 ≤ IC < 2). Pancreatitis is reported more frequently with this diabetes medication, warranting further investigation.
Study Setup
Data Input
Enter the data for your disproportionality analysis. The tool will automatically calculate all measures.
| Adverse Event Present | Adverse Event Absent | Total | |
|---|---|---|---|
| Drug of Interest |
(a)
|
(b)
|
15,000
(a+b)
|
| All Other Drugs |
(c)
|
(d)
|
185,000
(c+d)
|
| Total |
415
(a+c)
|
199,585
(b+d)
|
200,000
(N)
|
Alternatively, you can enter total values and let the tool calculate the contingency table:
Analysis Results
| Measure | Value | Interpretation |
|---|---|---|
| ROR | - | - |
| PRR | - | - |
| IC | - | - |
| Chi-Square | - | - |
Signal Assessment
| Measure | Threshold | Current Value | Met? |
|---|---|---|---|
| ROR | > 2.0 | - | - |
| PRR | > 2.0 | - | - |
| IC | > 1.0 | - | - |
| Case Count | > 3 | - | - |
Interpretation
Complete the analysis to see signal interpretation.
Complete the analysis to see clinical context.
Complete the analysis to see recommendations.
